Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice

Cytokine

Volumn 51, Issue 2, 2010, Pages 151-157

  Huang, Hai ^a   Li, Hong ^a   Zhou, Pei ^a   Ju, Dianwen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Influenza virus; Pneumonia; Protective effects; RHuGM CSF

Indexed keywords

PLACEBO; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RIBAVIRIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LUNG INJURY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT; SURVIVAL RATE; SURVIVAL TIME; VIRUS PNEUMONIA; ANIMAL; BAGG ALBINO MOUSE; HUMAN; LUNG; MONONUCLEAR CELL; MORTALITY; MOUSE; ORTHOMYXOVIRIDAE INFECTIONS; PATHOLOGY; PNEUMONIA, VIRAL; VIROLOGY;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

ANIMALS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; LEUKOCYTES, MONONUCLEAR; LUNG; MALE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, VIRAL; RECOMBINANT PROTEINS;

EID: 77954073077     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.04.001     Document Type: Article

References (33)

1. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459:931-939.
2. Keech M., Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics 2008, 26:911-924.
3. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
4. Metcalf D. Hematopoietic cytokines. Blood 2008, 111:485-491.
5. Babu K.S., Muthukumaran T., Antony A., Samuel S.D.P.S., Balamurali M., Murugan V., et al. Single step intein-mediated purification of hGMCSF expressed in salt-inducible E. coli. Biotechnol Lett 2009, 31:659-664.
6. Sardana R., Dudani A.K., Tackaberry E., Alli Z., Porter S., Rowlandson K., et al. Biologically active human GM-CSF produced in the seeds of transgenic rice plants. Transgenic Res 2008, 16:713-721.
7. Kim N.S., Kim T.G., Jang Y.S., Shin Y.J., Kwon T.H., Yang M.S. Improvement of recombinant hGM-CSF production by suppression of cysteine proteinase gene expression using RNA interference in a transgenic rice culture. Plant Mol Biol 2008, 68:263-275.
8. das Gracas Sasaki M., Foccacia R., de Messias-Reason I.J. Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection. Vaccine 2003, 21:4545-4549.
9. Wang X.L., Li J.X., Jiang P., Li Y.F., Zeshan B., Cao J., et al. GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge. Virus Res 2009, 143:24-32.
10. Coon C., Beagley K.W., Bao S. The role of granulocyte macrophage-colony stimulating factor in gastrointestinal immunity to salmonellosis. Scand J Immunol 2009, 70:106-115.
11. Jin S., Zhang Q.Y., Kang X.M., Wang J.X., Sun W.Z. Malignant melanoma therapy by chemotherapy and autoimmunity induced by cytokine. Cancer Biother Radiopharm 2009, 24:237-241.
12. Lutzky J., Weber R., Nunez Y., Gillett M., Spitler L. A phase 1 study of granulocyte macrophage colony-stimulating factor (Sargramostim) and escalating doses of thalidomide in patients with high-risk malignant melanoma. J Immunother 2009, 32:79-85.
13. Sato T., Eschelman D.J., Gonsalves C.F., Terai M., Chervoneva I., Mccue P.A., et al. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. J Clin Oncol 2008, 26:5436-5442.
14. Dai S., Wei D., Wu Z., Zhou X.Y., Wei X.M., Huang H.X., et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 2008, 16:782-790.
15. Mann A., Niekisch K., Schirmacher P., Blessing M. Granulocyte-macrophage colony-stimulating factor is essential for normal wound healing. J Investig Dermatol Symp Proc 2006, 11:87-92.
16. Elias E.G., Zapas J.L., McCarron E.C., Beam S.L., Hasskamp J.H., Culpepper W.J. Sequential administration of GM-CSF (Sargramostim (R)) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: an interim report of a phase II clinical trial. Cancer Biother Radiopharm 2008, 23:285-291.
17. Qiu J.T., Chang T.C., Lin C.T., Chen Y.M., Li F.Q., Soong Y.K., et al. Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag. Vaccine 2007, 25:253-263.
18. Zhai Y.Z., Li X.M., Zhou Y., Ma L., Feng G.H. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF. Intervirology 2009, 52:152-163.
19. Matsuda S., Akagawa K., Honda M., Yokota Y., Takebe Y., Takemori T. Suppression of HIV replication in human monocyte-derived macrophages induced by granulocyte/macrophage colony-stimulating factor. AIDS Res Hum Retroviruses 1995, 11:1031-1038.
20. Martin J., Bosch O., Moraleda G., Bartolome J., Quiroga J.A., Carreno V. Pliot study of recombinant human granulocyte-macrophage colony stimulating factor in the treatment of chronic hepatitis B. Hepatology 1993, 18:775-780.
21. Altamura M., Geronmo M.G., Nappi L., Ceci O., Loizzi P., Jirillo E. Successful treatment of herpes simplex virus recurrent genital infection with recombinant human (rh) granulocyte-macrophage colony stimulating factor (GM-CSF): a case report. Immunopharmacol Immunotoxicol 1997, 19:425-436.
22. Saravolac E.G., Kournikais B., Gorton L., Wong J.P. Effect of liposome-encapsulation on immunomodulating and antiviral activities of interferon-gamma. Antiviral Res 1996, 29:199-207.
23. Sigel M.M. Differences in the hemagglutinating and antigenic properties of strains of influenza virus isolated from one outbreak. J Immunol 1949, 62:81-95.
24. Sidwell R.W., Huffman J.H., Barnard D.L., Bailey K.W., Wong M.H., Morrison A., et al. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Antiviral Res 1998, 37:107-120.
25. Pozzolini M., Scarfi S., Benatti U., Giovine M.. Interference in MTT cell viability assay in activated macrophage cell line. Anal Biochem 2003, 313:338-341.
26. Shi Y.F., Liu C.H., Roberts A.I., Das J., Xu G.W., Ren G.W., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res 2006, 16:126-133.
27. Robertson S.A. GM-CSF regulation of embryo development and pregnancy. Cytokine Growth Factor Rev 2007, 18:287-298.
28. Baleeiro C.E.O., Christensen P.J., Morris S.B., Mendez M.P., Wilcoxen S.E., Paine R. GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress. Am J Physiol Lung Cell 2006, 291:1246-1255.
29. Takada A., Matsushita S., Ninomiya A., Kawaoka Y., Kida H. Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003, 21:3212-3218.
30. Yuki Y., Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity. Rev Med Virol 2003, 13:293-310.
31. Rosas M., Gordon S., Taylor P.R. Characterisation of the expression and function of the GM-CSF receptor alpha-chain in mice. Eur J Immunol 2007, 37:2518-2528.
32. Hansen G., Hercus T.R., McClure B.J., Stomski F.C., Dottore M., Powell J., et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 2008, 134:496-507.
33. Hartley C.A., Jackson D.C., Anders E.M. Two distinct serum mannose-binding lectins function as inhibitors of influenza virus: identification of bovine serum inhibitor as conglutinin. J Virol 1992, 66:4358-4363.